GROWTH HORMONE & IGF RESEARCH

Scope & Guideline

Transforming Understanding of Growth Factors

Introduction

Welcome to the GROWTH HORMONE & IGF RESEARCH information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of GROWTH HORMONE & IGF RESEARCH, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1096-6374
PublisherCHURCHILL LIVINGSTONE
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1998 to 2024
AbbreviationGROWTH HORM IGF RES / Growth Horm. IGF Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND

Aims and Scopes

The journal 'Growth Hormone & IGF Research' is dedicated to advancing the understanding of growth hormone (GH) and insulin-like growth factors (IGFs) in various biological contexts, emphasizing both clinical and preclinical research. It serves as a platform for the dissemination of novel findings related to GH and IGF signaling pathways, their roles in growth and metabolism, and the clinical implications of these hormones in health and disease.
  1. Clinical Implications of Growth Hormone Disorders:
    The journal focuses on the clinical aspects of growth hormone disorders, including acromegaly, growth hormone deficiency, and their management strategies. It aims to provide insights into treatment modalities and their effectiveness.
  2. Metabolic and Physiological Effects of IGFs:
    Research published in the journal explores the metabolic roles of insulin-like growth factors, including their impact on conditions like diabetes, obesity, and cardiovascular health, thus bridging endocrinology with metabolic diseases.
  3. Molecular Mechanisms and Signaling Pathways:
    The journal covers studies detailing the molecular mechanisms of GH and IGF actions, including receptor interactions, downstream signaling pathways, and genetic influences, contributing to the fundamental understanding of these growth factors.
  4. Pediatric and Adult Growth Disorders:
    A significant emphasis is placed on both pediatric and adult populations, examining growth disorders from childhood through adulthood, and addressing transitional care between these life stages.
  5. Innovative Therapeutic Approaches:
    The journal highlights innovative therapeutic approaches for managing growth-related conditions, including pharmacological advances, gene therapy, and novel treatment protocols.
The journal is witnessing a dynamic evolution in its thematic focus, with several emerging trends gaining traction in recent publications. These trends highlight the journal's responsiveness to new challenges and advancements in the field of growth hormone and IGF research.
  1. Comorbidities Associated with Growth Hormone Disorders:
    Recent papers increasingly focus on the comorbidities associated with growth hormone disorders, such as metabolic syndrome, cardiovascular diseases, and psychological impacts, emphasizing the multifaceted nature of these conditions.
  2. Patient-Centric Approaches and Perspectives:
    There is a growing trend towards understanding patient and caregiver perspectives in managing growth hormone deficiencies, highlighting the importance of quality of life and patient experience in treatment outcomes.
  3. Innovations in GH and IGF Therapy:
    Emerging themes include the exploration of novel therapeutic approaches, such as long-acting growth hormone formulations and gene therapies, reflecting advancements in treatment options and patient management strategies.
  4. Impact of GH on Neurological Health:
    Research is increasingly examining the role of growth hormone in neurological health, including its effects on cognitive function and recovery in conditions like traumatic brain injury, signaling a broader understanding of GH's systemic effects.
  5. Integration of Technology in Diagnosis and Treatment:
    The integration of digital technologies and data analytics in diagnosing and managing growth disorders is on the rise, illustrating the journal's adaptation to contemporary clinical practices.

Declining or Waning

While 'Growth Hormone & IGF Research' continues to thrive in several areas, certain themes have shown signs of declining prominence in recent publications. This shift may reflect evolving research interests and advancements in technology and treatment modalities.
  1. Historical Perspectives on GH and IGF:
    There appears to be a waning interest in historical perspectives and older treatment methodologies for growth hormone disorders, as researchers focus more on contemporary practices and novel interventions.
  2. Animal Models in GH Research:
    Research utilizing animal models to study growth hormone effects has become less frequent, possibly due to an increased focus on human clinical trials and translational research that directly impacts patient care.
  3. Basic Science of GH and IGF Interaction:
    The basic science exploring the interactions of GH and IGF at a cellular level has decreased, with a shift towards applied research that emphasizes clinical outcomes and therapeutic applications.

Similar Journals

Acta Endocrinologica-Bucharest

Exploring the frontiers of endocrine research.
Publisher: EDITURA ACAD ROMANEISSN: 1841-0987Frequency: 4 issues/year

Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.

Hormones-International Journal of Endocrinology and Metabolism

Transforming Understanding in Endocrinology and Metabolism
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

Aging Male

Empowering professionals in the field of male geriatrics.
Publisher: TAYLOR & FRANCIS LTDISSN: 1368-5538Frequency: 4 issues/year

Aging Male is an esteemed peer-reviewed journal published by Taylor & Francis Ltd, dedicated to the multidisciplinary field of geriatrics and gerontology. With an impressive impact factor, this journal ranks in the top quartile (Q2) of its categories, solidifying its reputation as a leading source of research and insights for professionals and academics in the field. Since transitioning to Open Access in 2021, Aging Male has broadened its reach, facilitating the dissemination of relevant research findings that address the complexities of aging in male populations globally. The journal accepts a wide range of contributions, including original research, reviews, and clinical studies, with particular emphasis on the biological, psychological, and social aspects of male aging. Researchers, clinicians, and students alike will find this journal an invaluable resource for advancing knowledge and practice in the dynamic landscape of geriatric medicine.

Expert Review of Endocrinology & Metabolism

Empowering professionals with cutting-edge insights in metabolism.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1744-6651Frequency: 4 issues/year

Expert Review of Endocrinology & Metabolism is a premier journal dedicated to advancing the field of endocrinology and metabolism, published by Routledge Journals, Taylor & Francis Ltd, in the United Kingdom. With a robust focus on the latest research, innovative treatments, and clinical practices, this journal serves as an essential resource for healthcare professionals, researchers, and students seeking to stay abreast of developments in diabetes, obesity, thyroid disorders, and other endocrine-related conditions. Achieving a commendable Q2 status in Endocrinology, Diabetes, and Metabolism in the 2023 ranking, Expert Review of Endocrinology & Metabolism holds strong standing with an impressive Scopus rank, placing it at the 53rd percentile among its peers. The journal embraces a comprehensive approach, offering critical reviews, original research articles, and insights on emerging trends and technologies in the field. Although not an open-access journal, it provides extensive access options for subscribers and institutions, encouraging ease of dissemination and academic engagement. Through its commitment to high-quality content, Expert Review of Endocrinology & Metabolism remains pivotal for professionals aiming to enhance their understanding and practice in this vital area of medicine.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Advancing knowledge in endocrinology and metabolism.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

ENDOCRINE RESEARCH

Illuminating the complexities of endocrinology.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Transforming Insights into Solutions for Children
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

JOURNAL OF ENDOCRINOLOGY

Pioneering Research in Endocrine Health
Publisher: BIOSCIENTIFICA LTDISSN: 0022-0795Frequency: 12 issues/year

JOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.

Hormone Research in Paediatrics

Unlocking the secrets of hormones in children's health.
Publisher: KARGERISSN: 1663-2818Frequency: 12 issues/year

Hormone Research in Paediatrics, published by KARGER, is a leading international journal dedicated to advancing the field of pediatric endocrinology. With its ISSN 1663-2818 and E-ISSN 1663-2826, it serves as a vital resource for researchers and professionals focused on the hormonal aspects affecting children's health. Housed in Switzerland, the journal benefits from a strong academic reputation and ranks in the prestigious Q1 category in Pediatrics, Perinatology, and Child Health, as well as maintaining Q2 status in Endocrinology, Diabetes, and Metabolism. Covering a time span from its inception in 1970 to the present day, Hormone Research in Paediatrics is committed to publishing high-quality original research, reviews, and clinical studies, making crucial contributions to our understanding of pediatric hormonal disorders and treatments. The journal incorporates open access options, fostering wider dissemination and accessibility of vital research findings, thus ensuring that significant advancements reach academics, professionals, and students globally.

Pituitary

Advancing Knowledge in Endocrinology and Beyond
Publisher: SPRINGERISSN: 1386-341XFrequency: 6 issues/year

Pituitary is a prominent academic journal dedicated to advancing the understanding of pituitary gland functions, disorders, and treatments within the sphere of Endocrinology, Diabetes, and Metabolism. Published by Springer in the Netherlands, this journal has established itself as a crucial resource for researchers and clinicians alike, as evidenced by its 2023 Category Quartiles ranking in Q2 and Q1, and a commendable Scopus ranking in both Medicine and Biochemistry. With a focus on innovative research and clinical advances, Pituitary covers a wide range of topics including hormone regulation, pituitary tumors, and endocrine therapies. While it does not currently offer Open Access options, the journal's rigorous peer-review process ensures that each article published contributes significantly to the scientific community's knowledge base. Researchers, professionals, and students will find Pituitary an invaluable resource for both current insights and ongoing developments in endocrine health.